Drugs / Curdlan sulfate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002100 | — | HIV infectious disease | AJI Pharma USA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Curdlan sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002100 ↗ |
| Route | Intravenous | “escalating single doses of intravenous curdlan sulfate are tested.” NCT00002100 ↗ |